Drug Type CpG ODN |
Synonyms |
Target |
Mechanism CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), CD23 agonists(Immunoglobulin epsilon Fc receptor agonists), TLR9 gene stimulators + [1] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Discovery | SE | - |